Fractyl Health (GUTS) Competitors $1.64 +0.06 (+3.80%) Closing price 04:00 PM EasternExtended Trading$1.62 -0.02 (-1.22%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS vs. SMLR, TMCI, NPCE, OM, CLPT, CATX, NNOX, SNWV, NYXH, and ZIMVShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Semler Scientific (SMLR), Treace Medical Concepts (TMCI), NeuroPace (NPCE), Outset Medical (OM), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), Sanuwave Health (SNWV), Nyxoah (NYXH), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Its Competitors Semler Scientific Treace Medical Concepts NeuroPace Outset Medical ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Sanuwave Health Nyxoah ZimVie Semler Scientific (NASDAQ:SMLR) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings. Which has more volatility and risk, SMLR or GUTS? Semler Scientific has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Do analysts rate SMLR or GUTS? Semler Scientific currently has a consensus price target of $71.00, suggesting a potential upside of 79.56%. Fractyl Health has a consensus price target of $11.00, suggesting a potential upside of 570.73%. Given Fractyl Health's higher possible upside, analysts plainly believe Fractyl Health is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SMLR or GUTS more profitable? Semler Scientific has a net margin of -60.69% compared to Fractyl Health's net margin of -73,864.52%. Semler Scientific's return on equity of 19.75% beat Fractyl Health's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific-60.69% 19.75% 15.47% Fractyl Health -73,864.52%-228.66%-76.74% Do institutionals and insiders have more ownership in SMLR or GUTS? 49.4% of Semler Scientific shares are held by institutional investors. 30.2% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, SMLR or GUTS? Semler Scientific has higher revenue and earnings than Fractyl Health. Semler Scientific is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M7.83$40.90M-$2.61-15.15Fractyl Health$90K892.52-$68.69M-$1.85-0.89 Does the media prefer SMLR or GUTS? In the previous week, Semler Scientific had 6 more articles in the media than Fractyl Health. MarketBeat recorded 6 mentions for Semler Scientific and 0 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.16 beat Semler Scientific's score of 0.19 indicating that Fractyl Health is being referred to more favorably in the news media. Company Overall Sentiment Semler Scientific Neutral Fractyl Health Positive SummarySemler Scientific beats Fractyl Health on 8 of the 15 factors compared between the two stocks. Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.38M$2.42B$5.54B$8.87BDividend YieldN/A1.77%5.39%4.10%P/E Ratio-0.898.7226.1419.88Price / Sales892.52663.86414.67113.66Price / CashN/A151.5836.1356.90Price / Book2.784.548.055.38Net Income-$68.69M$31.16M$3.15B$248.50M7 Day Performance-5.75%0.15%1.85%2.97%1 Month Performance-13.68%8.81%4.81%6.02%1 Year Performance-63.06%2.55%34.86%20.39% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health2.7505 of 5 stars$1.64+3.8%$11.00+570.7%-64.6%$77.38M$90K-0.89102Positive NewsSMLRSemler Scientific2.2992 of 5 stars$41.99+16.2%$71.00+69.1%+5.0%$403.02M$56.29M-16.09120Gap UpHigh Trading VolumeTMCITreace Medical Concepts2.5891 of 5 stars$5.74+4.2%$10.16+77.0%-7.2%$346.52M$209.36M-6.75250NPCENeuroPace3.2631 of 5 stars$10.57+1.5%$15.50+46.6%+43.2%$341.43M$79.91M-12.58170High Trading VolumeOMOutset Medical1.6856 of 5 stars$17.37-8.5%$27.00+55.4%-62.5%$336.37M$113.69M-0.60520News CoverageHigh Trading VolumeCLPTClearPoint Neuro2.2883 of 5 stars$11.36+0.9%$25.00+120.1%+111.3%$315.16M$31.39M-14.95110Positive NewsCATXPerspective Therapeutics1.6588 of 5 stars$4.11+18.8%$12.56+205.5%-70.7%$305.08M$1.43M0.0070NNOXNano-X Imaging1.877 of 5 stars$4.95-0.8%$9.50+91.9%-28.5%$288.32M$11.28M-5.50190News CoverageSNWVSanuwave HealthN/A$33.57-0.3%N/AN/A$288.15M$32.63M0.0040Positive NewsNYXHNyxoah3.2241 of 5 stars$7.83+1.6%$14.50+85.2%+7.4%$262.61M$4.89M-3.68110Positive NewsGap UpZIMVZimVie2.3526 of 5 stars$8.65-1.6%$16.33+88.8%-45.7%$244.78M$449.75M-12.181,770 Related Companies and Tools Related Companies Semler Scientific Alternatives Treace Medical Concepts Alternatives NeuroPace Alternatives Outset Medical Alternatives ClearPoint Neuro Alternatives Perspective Therapeutics Alternatives Nano-X Imaging Alternatives Sanuwave Health Alternatives Nyxoah Alternatives ZimVie Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GUTS) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
